Nadolol

CAS 220045-89-6 5 current records 1 historicalSmall Molecule

Who holds supplier records for Nadolol? 5 organisations hold a current record for Nadolol: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 3 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (2), Finland (1) and Germany (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Nadolol: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/nadolol

Reading the evidence

  • 5 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 2 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (5)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Nadolol. Country is the organisation's recorded country, not necessarily the manufacturing site.

India2Finland1Germany1Country not recorded for 1
Need Nadolol sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (3)

Certificates of Suitability on the EDQM register for Nadolol, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
MATRIX PHARMACORP PRIVATE LIMITED Sangareddy DistrictIN
CEP 2009-372 - Rev 05
Nadolol
Sept 2025—
EUROAPI GERMANY GmbH Frankfurt am MainDE
CEP 2010-058 - Rev 03
Nadolol
Mar 2025Inspected Mar 2024
Germany
BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. HyderabadIN
CEP 2017-209 - Rev 02
Nadolol
Jul 2024—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (1)

Organisations whose Type II DMFs for Nadolol are no longer active. These show a past filing, not current supply.

Show all 1 historical record
  • SYNCHEM CHEMICALS PRIVATE LTD
    Inactive DMF 11192 · filed Nov 1994

Overview

Nadolol is a non-selective beta-adrenergic blocker used in the management of hypertension and angina pectoris. It decreases heart rate, cardiac output, and blood pressure to improve cardiovascular function.

Chemical identity

IUPAC name
(2R,3S)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol
Canonical SMILES
CC(C)(C)NCC(COC1=CC=CC2=C1C[C@@H]([C@@H](C2)O)O)O
InChIKey
VWPOSFSPZNDTMJ-UCWKZMIHSA-N
Synonyms
Corgard API, corgard, corzide component nadolol, nsc-758430, sq-11725

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
beta-Adrenergic Blocker
Mechanism of action
Adrenergic beta-Antagonists

Therapeutic areas

Cardiovascular

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Nadolol?

5 organisations hold an active US FDA Type II Drug Master File or a CEP for Nadolol: BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), MATRIX PHARMACORP PRIVATE LTD (India), FERMION OY (Finland), SIGNA SA DE CV and EUROAPI GERMANY GMBH (Germany). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Nadolol Drug Master Files are active?

BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 31735), MATRIX PHARMACORP PRIVATE LTD (DMF 24968), FERMION OY (DMF 6247) and SIGNA SA DE CV (DMF 7426). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Nadolol records mean?

1 organisation has only inactive Type II DMFs for Nadolol. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Nadolol have a European Certificate of Suitability?

Yes. 3 organisations hold a valid CEP for Nadolol on the EDQM register, including MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District (IN), EUROAPI GERMANY GmbH Frankfurt am Main (DE) and BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. Hyderabad (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Nadolol supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Nadolol?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.